Relief Therapeutics Holding SA (RLFTF)

3.60
-0.10(-2.70%)
  • Volume:
    15,197
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.35 - 3.70

RLFTF Overview

Prev. Close
3.7
Day's Range
3.35-3.7
Revenue
16M
Open
3.35
52 wk Range
0.01-5.19
EPS
-4.8
Volume
15,197
Market Cap
36.09M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
793,221
P/E Ratio
-0.85
Beta
-14.14
1-Year Change
8,900%
Shares Outstanding
11,018,501
Next Earnings Date
-
What is your sentiment on Relief Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Relief Therapeutics Holding SA Company Profile

Relief Therapeutics Holding SA Company Profile

RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuyBuy
Technical IndicatorsStrong BuyBuyStrong SellStrong BuyStrong Buy
SummaryStrong BuyStrong BuyNeutralStrong BuyStrong Buy
  • Reason for the spike? Still pump and dump?
    0
    • Relief Therapeutics: Nrx wants to patent its anti-COVID formulation of aviptadil
      0
    • Still pump and dump. Is it now a good time to buy?
      0
  • https://www.relieftherapeutics.com/newsblog/relief-reports-that-its-u-s-collaboration-partner-has-announced-it-has-received-a-u-s-food-and-drug-administration-review-of-aviptadil-manufacturing-information
    0
    • With the lawsuit it's pretty much the end for this thing, right?
      0
      • Which lawsuit?
        0
      • Just found this now. Yes sounds the end
        0
    • good time to buy now. will definitely go up in the next few weeks
      0
      • Based on?
        0
    • 2q 2022 gona bi big
      0
      • Lots of potential but Still no revenue to report
        1
        • This stock is puzzling. No updates, suddenly up 20.30% out of the blue. This week, it's secured more funding, completed acquisitions, Aviptadil gets approval in Georgia plus commercial formulation... and the stock is down about 6-7% .... SMH x-/
          0
          • Ok this is bigNRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia
            0
            • Turns out it wasn’t that big…
              0
          • That's a nice start of the week
            0
            • This stock keeps doing this, falls gradually and then it's pumped o and volume another 20% only to fall again due to lack of news and meaningful updates.
              1